(Q38582698)

4 September 2017

title

Molecular cytopathology for thyroid nodules: A review of methodology and test performance (English)

1 reference

4 September 2017

Michiya Nishino

1

1 reference

4 September 2017

publication date

8 September 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

124

1 reference

4 September 2017

issue

1

1 reference

4 September 2017

page(s)

14-27

1 reference

The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

The Bethesda System For Reporting Thyroid Cytopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Multicenter clinical experience with the Afirma gene expression classifier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

The role of genetic markers in the evaluation and management of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Clinical diagnostic gene expression thyroid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

BRAFV600E mutation and papillary thyroid cancer: chicken or egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

When thyroid carcinoma goes bad: a morphological and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular genetics and diagnosis of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Integrated genomic characterization of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

The role of microRNA genes in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

MicroRNA deregulation in human thyroid papillary carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

The Putative PAX8/PPARγ Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARγ Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Classification of follicular cell-derived thyroid cancer by global RNA profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Inter- and intraobserver reproducibility of thyroid fine needle aspiration cytology: an analysis of discrepant cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Surgical utility of Afirma: effects of high cancer prevalence and oncocytic cell types in patients with indeterminate thyroid cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Lessons from early clinical experience with the Afirma gene expression classifier

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Should the thyroid AUS/FLUS category be further stratified by malignancy risk?

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Next-generation sequencing improves the diagnosis of thyroid FNA specimens with indeterminate cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21612

7 January 2021

Identifiers

DOI

10.1002/CNCY.21612

1 reference

4 September 2017

1 reference